Global Fertility Medicines Market Growth 2024-2030

March 2024 | 113 pages | ID: GB8BDC71A360EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

According to our LPI (LP Information) latest study, the global Fertility Medicines market size was valued at US$ 4535.9 million in 2023. With growing demand in downstream market, the Fertility Medicines is forecast to a readjusted size of US$ 6827.9 million by 2030 with a CAGR of 6.0% during review period.

The research report highlights the growth potential of the global Fertility Medicines market. Fertility Medicines are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Fertility Medicines. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Fertility Medicines market.

Fertility medicines

Infertility continues to pose a global health challenge due to demographic changes and ongoing lifestyle issues, including obesity, anxiety, stress and other factors that lead to delayed childbearing. For example, according to alcoholic beverage consumption statistics released in February 2023, approximately 63% of adults aged 18 and older in the United States drank alcohol between 2021 and 2022. Additionally, 12.5% of adults in the UK reported teetotaling, while the drinking rate among adults in the country was 71.2% (drinking at least once a week), according to data released by UK Alcohol Consumption Statistics in February 2023. Therefore, heavy drinking can affect fertility in both men and women. In turn, it is expected to boost demand for infertility drugs over the forecast period.

The low fertility rate prevalent among the population is also a key factor driving the market growth. For example, in July 2022, about 15% of U.S. couples and at least 180 million people worldwide were suffering from infertility, according to an article published by the U.S. National Library of Medicine.

Key Features:

The report on Fertility Medicines market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Fertility Medicines market. It may include historical data, market segmentation by Type (e.g., Parenteral, Oral), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Fertility Medicines market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Fertility Medicines market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Fertility Medicines industry. This include advancements in Fertility Medicines technology, Fertility Medicines new entrants, Fertility Medicines new investment, and other innovations that are shaping the future of Fertility Medicines.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Fertility Medicines market. It includes factors influencing customer ' purchasing decisions, preferences for Fertility Medicines product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Fertility Medicines market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Fertility Medicines market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Fertility Medicines market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Fertility Medicines industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Fertility Medicines market.

Market Segmentation:

Fertility Medicines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Segmentation by type
  • Parenteral
  • Oral
  • Others
Segmentation by application
  • Clinic
  • Hospitals
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Allergan Plc
  • Ferring BV
  • Merck KGaA
  • Novartis AG
  • Sanofi
  • Bayer AG
  • Pfizer Inc.
  • Abbott
  • Teva Pharmaceutical Industries
  • Livzon
Key Questions Addressed in this Report

What is the 10-year outlook for the global Fertility Medicines market?

What factors are driving Fertility Medicines market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Fertility Medicines market opportunities vary by end market size?

How does Fertility Medicines break out type, application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Fertility Medicines Annual Sales 2019-2030
  2.1.2 World Current & Future Analysis for Fertility Medicines by Geographic Region, 2019, 2023 & 2030
  2.1.3 World Current & Future Analysis for Fertility Medicines by Country/Region, 2019, 2023 & 2030
2.2 Fertility Medicines Segment by Type
  2.2.1 Parenteral
  2.2.2 Oral
  2.2.3 Others
2.3 Fertility Medicines Sales by Type
  2.3.1 Global Fertility Medicines Sales Market Share by Type (2019-2024)
  2.3.2 Global Fertility Medicines Revenue and Market Share by Type (2019-2024)
  2.3.3 Global Fertility Medicines Sale Price by Type (2019-2024)
2.4 Fertility Medicines Segment by Application
  2.4.1 Clinic
  2.4.2 Hospitals
2.5 Fertility Medicines Sales by Application
  2.5.1 Global Fertility Medicines Sale Market Share by Application (2019-2024)
  2.5.2 Global Fertility Medicines Revenue and Market Share by Application (2019-2024)
  2.5.3 Global Fertility Medicines Sale Price by Application (2019-2024)

3 GLOBAL FERTILITY MEDICINES BY COMPANY

3.1 Global Fertility Medicines Breakdown Data by Company
  3.1.1 Global Fertility Medicines Annual Sales by Company (2019-2024)
  3.1.2 Global Fertility Medicines Sales Market Share by Company (2019-2024)
3.2 Global Fertility Medicines Annual Revenue by Company (2019-2024)
  3.2.1 Global Fertility Medicines Revenue by Company (2019-2024)
  3.2.2 Global Fertility Medicines Revenue Market Share by Company (2019-2024)
3.3 Global Fertility Medicines Sale Price by Company
3.4 Key Manufacturers Fertility Medicines Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Fertility Medicines Product Location Distribution
  3.4.2 Players Fertility Medicines Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR FERTILITY MEDICINES BY GEOGRAPHIC REGION

4.1 World Historic Fertility Medicines Market Size by Geographic Region (2019-2024)
  4.1.1 Global Fertility Medicines Annual Sales by Geographic Region (2019-2024)
  4.1.2 Global Fertility Medicines Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Fertility Medicines Market Size by Country/Region (2019-2024)
  4.2.1 Global Fertility Medicines Annual Sales by Country/Region (2019-2024)
  4.2.2 Global Fertility Medicines Annual Revenue by Country/Region (2019-2024)
4.3 Americas Fertility Medicines Sales Growth
4.4 APAC Fertility Medicines Sales Growth
4.5 Europe Fertility Medicines Sales Growth
4.6 Middle East & Africa Fertility Medicines Sales Growth

5 AMERICAS

5.1 Americas Fertility Medicines Sales by Country
  5.1.1 Americas Fertility Medicines Sales by Country (2019-2024)
  5.1.2 Americas Fertility Medicines Revenue by Country (2019-2024)
5.2 Americas Fertility Medicines Sales by Type
5.3 Americas Fertility Medicines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Fertility Medicines Sales by Region
  6.1.1 APAC Fertility Medicines Sales by Region (2019-2024)
  6.1.2 APAC Fertility Medicines Revenue by Region (2019-2024)
6.2 APAC Fertility Medicines Sales by Type
6.3 APAC Fertility Medicines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Fertility Medicines by Country
  7.1.1 Europe Fertility Medicines Sales by Country (2019-2024)
  7.1.2 Europe Fertility Medicines Revenue by Country (2019-2024)
7.2 Europe Fertility Medicines Sales by Type
7.3 Europe Fertility Medicines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Fertility Medicines by Country
  8.1.1 Middle East & Africa Fertility Medicines Sales by Country (2019-2024)
  8.1.2 Middle East & Africa Fertility Medicines Revenue by Country (2019-2024)
8.2 Middle East & Africa Fertility Medicines Sales by Type
8.3 Middle East & Africa Fertility Medicines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Fertility Medicines
10.3 Manufacturing Process Analysis of Fertility Medicines
10.4 Industry Chain Structure of Fertility Medicines

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Fertility Medicines Distributors
11.3 Fertility Medicines Customer

12 WORLD FORECAST REVIEW FOR FERTILITY MEDICINES BY GEOGRAPHIC REGION

12.1 Global Fertility Medicines Market Size Forecast by Region
  12.1.1 Global Fertility Medicines Forecast by Region (2025-2030)
  12.1.2 Global Fertility Medicines Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Fertility Medicines Forecast by Type
12.7 Global Fertility Medicines Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Allergan Plc
  13.1.1 Allergan Plc Company Information
  13.1.2 Allergan Plc Fertility Medicines Product Portfolios and Specifications
  13.1.3 Allergan Plc Fertility Medicines Sales, Revenue, Price and Gross Margin (2019-2024)
  13.1.4 Allergan Plc Main Business Overview
  13.1.5 Allergan Plc Latest Developments
13.2 Ferring BV
  13.2.1 Ferring BV Company Information
  13.2.2 Ferring BV Fertility Medicines Product Portfolios and Specifications
  13.2.3 Ferring BV Fertility Medicines Sales, Revenue, Price and Gross Margin (2019-2024)
  13.2.4 Ferring BV Main Business Overview
  13.2.5 Ferring BV Latest Developments
13.3 Merck KGaA
  13.3.1 Merck KGaA Company Information
  13.3.2 Merck KGaA Fertility Medicines Product Portfolios and Specifications
  13.3.3 Merck KGaA Fertility Medicines Sales, Revenue, Price and Gross Margin (2019-2024)
  13.3.4 Merck KGaA Main Business Overview
  13.3.5 Merck KGaA Latest Developments
13.4 Novartis AG
  13.4.1 Novartis AG Company Information
  13.4.2 Novartis AG Fertility Medicines Product Portfolios and Specifications
  13.4.3 Novartis AG Fertility Medicines Sales, Revenue, Price and Gross Margin (2019-2024)
  13.4.4 Novartis AG Main Business Overview
  13.4.5 Novartis AG Latest Developments
13.5 Sanofi
  13.5.1 Sanofi Company Information
  13.5.2 Sanofi Fertility Medicines Product Portfolios and Specifications
  13.5.3 Sanofi Fertility Medicines Sales, Revenue, Price and Gross Margin (2019-2024)
  13.5.4 Sanofi Main Business Overview
  13.5.5 Sanofi Latest Developments
13.6 Bayer AG
  13.6.1 Bayer AG Company Information
  13.6.2 Bayer AG Fertility Medicines Product Portfolios and Specifications
  13.6.3 Bayer AG Fertility Medicines Sales, Revenue, Price and Gross Margin (2019-2024)
  13.6.4 Bayer AG Main Business Overview
  13.6.5 Bayer AG Latest Developments
13.7 Pfizer Inc.
  13.7.1 Pfizer Inc. Company Information
  13.7.2 Pfizer Inc. Fertility Medicines Product Portfolios and Specifications
  13.7.3 Pfizer Inc. Fertility Medicines Sales, Revenue, Price and Gross Margin (2019-2024)
  13.7.4 Pfizer Inc. Main Business Overview
  13.7.5 Pfizer Inc. Latest Developments
13.8 Abbott
  13.8.1 Abbott Company Information
  13.8.2 Abbott Fertility Medicines Product Portfolios and Specifications
  13.8.3 Abbott Fertility Medicines Sales, Revenue, Price and Gross Margin (2019-2024)
  13.8.4 Abbott Main Business Overview
  13.8.5 Abbott Latest Developments
13.9 Teva Pharmaceutical Industries
  13.9.1 Teva Pharmaceutical Industries Company Information
  13.9.2 Teva Pharmaceutical Industries Fertility Medicines Product Portfolios and Specifications
  13.9.3 Teva Pharmaceutical Industries Fertility Medicines Sales, Revenue, Price and Gross Margin (2019-2024)
  13.9.4 Teva Pharmaceutical Industries Main Business Overview
  13.9.5 Teva Pharmaceutical Industries Latest Developments
13.10 Livzon
  13.10.1 Livzon Company Information
  13.10.2 Livzon Fertility Medicines Product Portfolios and Specifications
  13.10.3 Livzon Fertility Medicines Sales, Revenue, Price and Gross Margin (2019-2024)
  13.10.4 Livzon Main Business Overview
  13.10.5 Livzon Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES

Table 1. Fertility Medicines Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Fertility Medicines Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Parenteral
Table 4. Major Players of Oral
Table 5. Major Players of Others
Table 6. Global Fertility Medicines Sales by Type (2019-2024) & (K Units)
Table 7. Global Fertility Medicines Sales Market Share by Type (2019-2024)
Table 8. Global Fertility Medicines Revenue by Type (2019-2024) & ($ million)
Table 9. Global Fertility Medicines Revenue Market Share by Type (2019-2024)
Table 10. Global Fertility Medicines Sale Price by Type (2019-2024) & (USD/Unit)
Table 11. Global Fertility Medicines Sales by Application (2019-2024) & (K Units)
Table 12. Global Fertility Medicines Sales Market Share by Application (2019-2024)
Table 13. Global Fertility Medicines Revenue by Application (2019-2024)
Table 14. Global Fertility Medicines Revenue Market Share by Application (2019-2024)
Table 15. Global Fertility Medicines Sale Price by Application (2019-2024) & (USD/Unit)
Table 16. Global Fertility Medicines Sales by Company (2019-2024) & (K Units)
Table 17. Global Fertility Medicines Sales Market Share by Company (2019-2024)
Table 18. Global Fertility Medicines Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Fertility Medicines Revenue Market Share by Company (2019-2024)
Table 20. Global Fertility Medicines Sale Price by Company (2019-2024) & (USD/Unit)
Table 21. Key Manufacturers Fertility Medicines Producing Area Distribution and Sales Area
Table 22. Players Fertility Medicines Products Offered
Table 23. Fertility Medicines Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Fertility Medicines Sales by Geographic Region (2019-2024) & (K Units)
Table 27. Global Fertility Medicines Sales Market Share Geographic Region (2019-2024)
Table 28. Global Fertility Medicines Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Fertility Medicines Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Fertility Medicines Sales by Country/Region (2019-2024) & (K Units)
Table 31. Global Fertility Medicines Sales Market Share by Country/Region (2019-2024)
Table 32. Global Fertility Medicines Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Fertility Medicines Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Fertility Medicines Sales by Country (2019-2024) & (K Units)
Table 35. Americas Fertility Medicines Sales Market Share by Country (2019-2024)
Table 36. Americas Fertility Medicines Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Fertility Medicines Revenue Market Share by Country (2019-2024)
Table 38. Americas Fertility Medicines Sales by Type (2019-2024) & (K Units)
Table 39. Americas Fertility Medicines Sales by Application (2019-2024) & (K Units)
Table 40. APAC Fertility Medicines Sales by Region (2019-2024) & (K Units)
Table 41. APAC Fertility Medicines Sales Market Share by Region (2019-2024)
Table 42. APAC Fertility Medicines Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Fertility Medicines Revenue Market Share by Region (2019-2024)
Table 44. APAC Fertility Medicines Sales by Type (2019-2024) & (K Units)
Table 45. APAC Fertility Medicines Sales by Application (2019-2024) & (K Units)
Table 46. Europe Fertility Medicines Sales by Country (2019-2024) & (K Units)
Table 47. Europe Fertility Medicines Sales Market Share by Country (2019-2024)
Table 48. Europe Fertility Medicines Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Fertility Medicines Revenue Market Share by Country (2019-2024)
Table 50. Europe Fertility Medicines Sales by Type (2019-2024) & (K Units)
Table 51. Europe Fertility Medicines Sales by Application (2019-2024) & (K Units)
Table 52. Middle East & Africa Fertility Medicines Sales by Country (2019-2024) & (K Units)
Table 53. Middle East & Africa Fertility Medicines Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Fertility Medicines Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Fertility Medicines Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Fertility Medicines Sales by Type (2019-2024) & (K Units)
Table 57. Middle East & Africa Fertility Medicines Sales by Application (2019-2024) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Fertility Medicines
Table 59. Key Market Challenges & Risks of Fertility Medicines
Table 60. Key Industry Trends of Fertility Medicines
Table 61. Fertility Medicines Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Fertility Medicines Distributors List
Table 64. Fertility Medicines Customer List
Table 65. Global Fertility Medicines Sales Forecast by Region (2025-2030) & (K Units)
Table 66. Global Fertility Medicines Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Fertility Medicines Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Americas Fertility Medicines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Fertility Medicines Sales Forecast by Region (2025-2030) & (K Units)
Table 70. APAC Fertility Medicines Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Fertility Medicines Sales Forecast by Country (2025-2030) & (K Units)
Table 72. Europe Fertility Medicines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Fertility Medicines Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Middle East & Africa Fertility Medicines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Fertility Medicines Sales Forecast by Type (2025-2030) & (K Units)
Table 76. Global Fertility Medicines Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global Fertility Medicines Sales Forecast by Application (2025-2030) & (K Units)
Table 78. Global Fertility Medicines Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. Allergan Plc Basic Information, Fertility Medicines Manufacturing Base, Sales Area and Its Competitors
Table 80. Allergan Plc Fertility Medicines Product Portfolios and Specifications
Table 81. Allergan Plc Fertility Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. Allergan Plc Main Business
Table 83. Allergan Plc Latest Developments
Table 84. Ferring BV Basic Information, Fertility Medicines Manufacturing Base, Sales Area and Its Competitors
Table 85. Ferring BV Fertility Medicines Product Portfolios and Specifications
Table 86. Ferring BV Fertility Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. Ferring BV Main Business
Table 88. Ferring BV Latest Developments
Table 89. Merck KGaA Basic Information, Fertility Medicines Manufacturing Base, Sales Area and Its Competitors
Table 90. Merck KGaA Fertility Medicines Product Portfolios and Specifications
Table 91. Merck KGaA Fertility Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. Merck KGaA Main Business
Table 93. Merck KGaA Latest Developments
Table 94. Novartis AG Basic Information, Fertility Medicines Manufacturing Base, Sales Area and Its Competitors
Table 95. Novartis AG Fertility Medicines Product Portfolios and Specifications
Table 96. Novartis AG Fertility Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. Novartis AG Main Business
Table 98. Novartis AG Latest Developments
Table 99. Sanofi Basic Information, Fertility Medicines Manufacturing Base, Sales Area and Its Competitors
Table 100. Sanofi Fertility Medicines Product Portfolios and Specifications
Table 101. Sanofi Fertility Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. Sanofi Main Business
Table 103. Sanofi Latest Developments
Table 104. Bayer AG Basic Information, Fertility Medicines Manufacturing Base, Sales Area and Its Competitors
Table 105. Bayer AG Fertility Medicines Product Portfolios and Specifications
Table 106. Bayer AG Fertility Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 107. Bayer AG Main Business
Table 108. Bayer AG Latest Developments
Table 109. Pfizer Inc. Basic Information, Fertility Medicines Manufacturing Base, Sales Area and Its Competitors
Table 110. Pfizer Inc. Fertility Medicines Product Portfolios and Specifications
Table 111. Pfizer Inc. Fertility Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 112. Pfizer Inc. Main Business
Table 113. Pfizer Inc. Latest Developments
Table 114. Abbott Basic Information, Fertility Medicines Manufacturing Base, Sales Area and Its Competitors
Table 115. Abbott Fertility Medicines Product Portfolios and Specifications
Table 116. Abbott Fertility Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 117. Abbott Main Business
Table 118. Abbott Latest Developments
Table 119. Teva Pharmaceutical Industries Basic Information, Fertility Medicines Manufacturing Base, Sales Area and Its Competitors
Table 120. Teva Pharmaceutical Industries Fertility Medicines Product Portfolios and Specifications
Table 121. Teva Pharmaceutical Industries Fertility Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 122. Teva Pharmaceutical Industries Main Business
Table 123. Teva Pharmaceutical Industries Latest Developments
Table 124. Livzon Basic Information, Fertility Medicines Manufacturing Base, Sales Area and Its Competitors
Table 125. Livzon Fertility Medicines Product Portfolios and Specifications
Table 126. Livzon Fertility Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 127. Livzon Main Business
Table 128. Livzon Latest Developments

LIST OF FIGURES

Figure 1. Picture of Fertility Medicines
Figure 2. Fertility Medicines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Fertility Medicines Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Fertility Medicines Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Fertility Medicines Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Parenteral
Figure 10. Product Picture of Oral
Figure 11. Product Picture of Others
Figure 12. Global Fertility Medicines Sales Market Share by Type in 2023
Figure 13. Global Fertility Medicines Revenue Market Share by Type (2019-2024)
Figure 14. Fertility Medicines Consumed in Clinic
Figure 15. Global Fertility Medicines Market: Clinic (2019-2024) & (K Units)
Figure 16. Fertility Medicines Consumed in Hospitals
Figure 17. Global Fertility Medicines Market: Hospitals (2019-2024) & (K Units)
Figure 18. Global Fertility Medicines Sales Market Share by Application (2023)
Figure 19. Global Fertility Medicines Revenue Market Share by Application in 2023
Figure 20. Fertility Medicines Sales Market by Company in 2023 (K Units)
Figure 21. Global Fertility Medicines Sales Market Share by Company in 2023
Figure 22. Fertility Medicines Revenue Market by Company in 2023 ($ Million)
Figure 23. Global Fertility Medicines Revenue Market Share by Company in 2023
Figure 24. Global Fertility Medicines Sales Market Share by Geographic Region (2019-2024)
Figure 25. Global Fertility Medicines Revenue Market Share by Geographic Region in 2023
Figure 26. Americas Fertility Medicines Sales 2019-2024 (K Units)
Figure 27. Americas Fertility Medicines Revenue 2019-2024 ($ Millions)
Figure 28. APAC Fertility Medicines Sales 2019-2024 (K Units)
Figure 29. APAC Fertility Medicines Revenue 2019-2024 ($ Millions)
Figure 30. Europe Fertility Medicines Sales 2019-2024 (K Units)
Figure 31. Europe Fertility Medicines Revenue 2019-2024 ($ Millions)
Figure 32. Middle East & Africa Fertility Medicines Sales 2019-2024 (K Units)
Figure 33. Middle East & Africa Fertility Medicines Revenue 2019-2024 ($ Millions)
Figure 34. Americas Fertility Medicines Sales Market Share by Country in 2023
Figure 35. Americas Fertility Medicines Revenue Market Share by Country in 2023
Figure 36. Americas Fertility Medicines Sales Market Share by Type (2019-2024)
Figure 37. Americas Fertility Medicines Sales Market Share by Application (2019-2024)
Figure 38. United States Fertility Medicines Revenue Growth 2019-2024 ($ Millions)
Figure 39. Canada Fertility Medicines Revenue Growth 2019-2024 ($ Millions)
Figure 40. Mexico Fertility Medicines Revenue Growth 2019-2024 ($ Millions)
Figure 41. Brazil Fertility Medicines Revenue Growth 2019-2024 ($ Millions)
Figure 42. APAC Fertility Medicines Sales Market Share by Region in 2023
Figure 43. APAC Fertility Medicines Revenue Market Share by Regions in 2023
Figure 44. APAC Fertility Medicines Sales Market Share by Type (2019-2024)
Figure 45. APAC Fertility Medicines Sales Market Share by Application (2019-2024)
Figure 46. China Fertility Medicines Revenue Growth 2019-2024 ($ Millions)
Figure 47. Japan Fertility Medicines Revenue Growth 2019-2024 ($ Millions)
Figure 48. South Korea Fertility Medicines Revenue Growth 2019-2024 ($ Millions)
Figure 49. Southeast Asia Fertility Medicines Revenue Growth 2019-2024 ($ Millions)
Figure 50. India Fertility Medicines Revenue Growth 2019-2024 ($ Millions)
Figure 51. Australia Fertility Medicines Revenue Growth 2019-2024 ($ Millions)
Figure 52. China Taiwan Fertility Medicines Revenue Growth 2019-2024 ($ Millions)
Figure 53. Europe Fertility Medicines Sales Market Share by Country in 2023
Figure 54. Europe Fertility Medicines Revenue Market Share by Country in 2023
Figure 55. Europe Fertility Medicines Sales Market Share by Type (2019-2024)
Figure 56. Europe Fertility Medicines Sales Market Share by Application (2019-2024)
Figure 57. Germany Fertility Medicines Revenue Growth 2019-2024 ($ Millions)
Figure 58. France Fertility Medicines Revenue Growth 2019-2024 ($ Millions)
Figure 59. UK Fertility Medicines Revenue Growth 2019-2024 ($ Millions)
Figure 60. Italy Fertility Medicines Revenue Growth 2019-2024 ($ Millions)
Figure 61. Russia Fertility Medicines Revenue Growth 2019-2024 ($ Millions)
Figure 62. Middle East & Africa Fertility Medicines Sales Market Share by Country in 2023
Figure 63. Middle East & Africa Fertility Medicines Revenue Market Share by Country in 2023
Figure 64. Middle East & Africa Fertility Medicines Sales Market Share by Type (2019-2024)
Figure 65. Middle East & Africa Fertility Medicines Sales Market Share by Application (2019-2024)
Figure 66. Egypt Fertility Medicines Revenue Growth 2019-2024 ($ Millions)
Figure 67. South Africa Fertility Medicines Revenue Growth 2019-2024 ($ Millions)
Figure 68. Israel Fertility Medicines Revenue Growth 2019-2024 ($ Millions)
Figure 69. Turkey Fertility Medicines Revenue Growth 2019-2024 ($ Millions)
Figure 70. GCC Country Fertility Medicines Revenue Growth 2019-2024 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Fertility Medicines in 2023
Figure 72. Manufacturing Process Analysis of Fertility Medicines
Figure 73. Industry Chain Structure of Fertility Medicines
Figure 74. Channels of Distribution
Figure 75. Global Fertility Medicines Sales Market Forecast by Region (2025-2030)
Figure 76. Global Fertility Medicines Revenue Market Share Forecast by Region (2025-2030)
Figure 77. Global Fertility Medicines Sales Market Share Forecast by Type (2025-2030)
Figure 78. Global Fertility Medicines Revenue Market Share Forecast by Type (2025-2030)
Figure 79. Global Fertility Medicines Sales Market Share Forecast by Application (2025-2030)
Figure 80. Global Fertility Medicines Revenue Market Share Forecast by Application (2025-2030)


More Publications